ANGIODYNAMICS INC — Director's Dealing 2013

Feb 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2013-02-01

Reporting Person: Frost Mark T (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-01	Common Stock	A	20000	—	Acquired	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-01	Non-Qualified Stock Option (right to buy)	$12.39	A	100000	Acquired	2020-02-01	Common Stock (100000)	Direct

Footnotes

F1: The acquisition of shares of 20,000 common stock represents 20,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal installments beginning on 11/30/2013.

F2: Options for 25% of the shares are each exercisable on 11/30/2013, 11/30/2014, 11/30/2015 and 11/30/2016, respectively.